Switch to:
Also traded in: Brazil, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.74
NYSE:AET's Cash-to-Debt is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. NYSE:AET: 0.74 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:AET' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32  Med: 9.73 Max: N/A
Current: 0.74
Equity-to-Asset 0.25
NYSE:AET's Equity-to-Asset is ranked lower than
74% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. NYSE:AET: 0.25 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:AET' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.2 Max: 0.3
Current: 0.25
0.06
0.3
Interest Coverage 4.61
NYSE:AET's Interest Coverage is ranked lower than
64% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.59 vs. NYSE:AET: 4.61 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:AET' s Interest Coverage Range Over the Past 10 Years
Min: 4.61  Med: 12.26 Max: 15.48
Current: 4.61
4.61
15.48
Piotroski F-Score: 6
Altman Z-Score: 2.14
Beneish M-Score: -2.51
WACC vs ROIC
5.15%
9.82%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 4.97
NYSE:AET's Operating Margin % is ranked higher than
74% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.07 vs. NYSE:AET: 4.97 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:AET' s Operating Margin % Range Over the Past 10 Years
Min: 4.97  Med: 7.76 Max: 10.89
Current: 4.97
4.97
10.89
Net Margin % 1.84
NYSE:AET's Net Margin % is ranked higher than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.91 vs. NYSE:AET: 1.84 )
Ranked among companies with meaningful Net Margin % only.
NYSE:AET' s Net Margin % Range Over the Past 10 Years
Min: 1.84  Med: 4.26 Max: 6.63
Current: 1.84
1.84
6.63
ROE % 6.79
NYSE:AET's ROE % is ranked higher than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.02 vs. NYSE:AET: 6.79 )
Ranked among companies with meaningful ROE % only.
NYSE:AET' s ROE % Range Over the Past 10 Years
Min: 6.79  Med: 15.65 Max: 19.85
Current: 6.79
6.79
19.85
ROA % 1.78
NYSE:AET's ROA % is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.98 vs. NYSE:AET: 1.78 )
Ranked among companies with meaningful ROA % only.
NYSE:AET' s ROA % Range Over the Past 10 Years
Min: 1.78  Med: 4.05 Max: 5.2
Current: 1.78
1.78
5.2
ROC (Joel Greenblatt) % 461.02
NYSE:AET's ROC (Joel Greenblatt) % is ranked higher than
89% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 77.30 vs. NYSE:AET: 461.02 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:AET' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 421.13  Med: 565.4 Max: 919.39
Current: 461.02
421.13
919.39
3-Year Revenue Growth Rate 10.60
NYSE:AET's 3-Year Revenue Growth Rate is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. NYSE:AET: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:AET' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.3 Max: 22
Current: 10.6
-15.7
22
3-Year EBITDA Growth Rate 11.60
NYSE:AET's 3-Year EBITDA Growth Rate is ranked higher than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.60 vs. NYSE:AET: 11.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:AET' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.6 Max: 76.7
Current: 11.6
0
76.7
3-Year EPS without NRI Growth Rate 6.30
NYSE:AET's 3-Year EPS without NRI Growth Rate is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.30 vs. NYSE:AET: 6.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:AET' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -13  Med: 6.4 Max: 63.9
Current: 6.3
-13
63.9
GuruFocus has detected 7 Warning Signs with Aetna Inc $NYSE:AET.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:AET's 30-Y Financials

Financials (Next Earnings Date: 2017-08-02 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

AET Guru Trades in Q2 2016

Paul Tudor Jones 2,200 sh (New)
Lee Ainslie 5,330 sh (+17.92%)
Diamond Hill Capital 795,119 sh (+0.84%)
Vanguard Health Care Fund 8,174,089 sh (unchged)
Jeff Auxier 5,315 sh (unchged)
RS Investment Management 2,305 sh (unchged)
David Dreman 9,854 sh (unchged)
Larry Robbins 5,179,716 sh (unchged)
Richard Pzena 155,102 sh (-0.06%)
John Buckingham 91,818 sh (-2.84%)
First Pacific Advisors 25,950 sh (-8.63%)
Pioneer Investments 1,278,820 sh (-10.31%)
Jeremy Grantham 850,567 sh (-20.72%)
Jim Simons 315,790 sh (-23.39%)
Andreas Halvorsen 961,700 sh (-75.07%)
Joel Greenblatt 15,622 sh (-76.78%)
George Soros 28,104 sh (-84.03%)
» More
Q3 2016

AET Guru Trades in Q3 2016

Chris Davis 1,504,313 sh (New)
Louis Moore Bacon 2,471 sh (New)
Paul Tudor Jones 9,710 sh (+341.36%)
Jim Simons 1,105,682 sh (+250.13%)
Joel Greenblatt 25,149 sh (+60.98%)
Diamond Hill Capital 1,078,124 sh (+35.59%)
Richard Pzena 155,248 sh (+0.09%)
Jeff Auxier 5,316 sh (+0.02%)
Vanguard Health Care Fund 8,174,089 sh (unchged)
Lee Ainslie 5,330 sh (unchged)
Larry Robbins 5,179,716 sh (unchged)
First Pacific Advisors Sold Out
George Soros Sold Out
Andreas Halvorsen Sold Out
John Buckingham 89,444 sh (-2.59%)
Pioneer Investments 1,232,493 sh (-3.62%)
David Dreman 9,163 sh (-7.01%)
Jeremy Grantham 201,681 sh (-76.29%)
» More
Q4 2016

AET Guru Trades in Q4 2016

Ray Dalio 189,000 sh (New)
David Swensen 2,240 sh (New)
John Burbank 69,424 sh (New)
Jana Partners 892,719 sh (New)
Steven Cohen 125,469 sh (New)
George Soros 31,000 sh (New)
Lee Ainslie 2,229,816 sh (+41735.20%)
Chris Davis 3,937,198 sh (+161.73%)
Jim Simons 2,842,782 sh (+157.11%)
Joel Greenblatt 37,850 sh (+50.50%)
Diamond Hill Capital 1,547,498 sh (+43.54%)
Larry Robbins 5,194,064 sh (+0.28%)
Richard Pzena 155,248 sh (unchged)
Jana Partners 2,100,000 sh (unchged)
Jeff Auxier 5,316 sh (unchged)
John Buckingham 87,655 sh (-2.00%)
Paul Tudor Jones 9,411 sh (-3.08%)
Vanguard Health Care Fund 6,754,289 sh (-17.37%)
Jeremy Grantham 71,644 sh (-64.48%)
Pioneer Investments 90,499 sh (-92.66%)
David Dreman 343 sh (-96.26%)
» More
Q1 2017

AET Guru Trades in Q1 2017

Eaton Vance Worldwide Health Sciences Fund 191,137 sh (New)
Louis Moore Bacon 25,000 sh (+911.74%)
Steven Cohen 228,300 sh (+81.96%)
Paul Tudor Jones 16,335 sh (+73.57%)
Jana Partners 1,450,016 sh (+62.43%)
Joel Greenblatt 44,978 sh (+18.83%)
Jim Simons 3,111,482 sh (+9.45%)
Diamond Hill Capital 1,656,372 sh (+7.04%)
Chris Davis 4,163,857 sh (+5.76%)
John Burbank Sold Out
David Dreman Sold Out
David Swensen Sold Out
George Soros Sold Out
Jeff Auxier 5,307 sh (-0.17%)
Richard Pzena 154,946 sh (-0.19%)
Pioneer Investments 90,146 sh (-0.39%)
Larry Robbins 5,029,073 sh (-3.18%)
John Buckingham 82,287 sh (-6.12%)
Vanguard Health Care Fund 5,230,989 sh (-22.55%)
Ray Dalio 85,970 sh (-54.51%)
Lee Ainslie 987,480 sh (-55.71%)
Jeremy Grantham 24,877 sh (-65.28%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:AET

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTX, NYSE:CI, NAS:ESRX, NYSE:HUM, NYSE:CVS, NYSE:CNC, NYSE:WCG, NYSE:MOH, OTCPK:QULRY, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:WCUI, OTCPK:OPRX, NAS:CNXR, NYSE:UNH » details
Traded in other countries:AETB34.Brazil, HE8.Germany,
Headquarter Location:USA
Aetna Inc is a health care benefit company. The Company offers traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans.

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This member count will increase significantly if the firm is able to close the Humana acquisition. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna has a large nationwide operation and competes in most major U.S. geographies.

Top Ranked Articles about Aetna Inc

Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna Vanguard Health Care Fund's largest 1st-quarter trades
Edward Owens has managed the Vanguard Health Care Fund (Trades, Portfolio) since its inception in May 1984. It invests primarily in health care companies. Read more...
Insiders Roundup: Facebook, General Electric, Aetna The largest insider trades of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “March 2017” and All Insider Sales to “$5,000,000+.” Read more...
Eaton Vance Worldwide Health Sciences Fund Adds 4 Stocks to Portfolio Health care fund reports fourth-quarter activity
Jason Kritzer, vice president of Eaton Vance Management, invests in companies with a bottom-up, proprietary research approach. The portfolio manager of the Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) invested in four companies during the first quarter: Aetna Inc. (NYSE:AET), Humana Inc. (NYSE:HUM), Hologic Inc. (NASDAQ:HOLX) and Teleflex Inc. (NYSE:TFX) Read more...
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna Inc. (AET) & Lead Plaintiff Deadline - March 27, 2017

NEW YORK, March 24, 2017 (GLOBE NEWSWIRE) -- -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aetna Inc. (“Aetna” or the “Company”) (:AET) and certain of its officers, on behalf of shareholders who purchased Aetna securities between August 15, 2016 and January 20, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/aet. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives tried to influence Aetna’s participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its involvement in public health insurance exchanges if the Department of Justice (“DOJ”) tried to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) consequently, Defendants’ statements regarding Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/aet or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

Read more...
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, March 24, 2017 (GLOBE NEWSWIRE) -- Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Aetna Inc. (“Aetna” or the “Company”) (:AET) concerning possible violations of federal securities laws. Investors who purchased or otherwise acquired shares between August 15, 2016 and January 20, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected]. No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member. The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: Aetna and its senior executives tried to influence Aetna's participation in the Public Exchanges for positive treatment from regulators regarding the Humana acquisition; that the Company threatened to cut back its participation in public health insurance exchanges if the Department of Justice ("DOJ") tried to block the merger; that Aetna withdraw from some public health insurance exchanges to complete its threat of leaving the marketplace once the DOJ filed suit to better its litigation; that Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and that due to the above, Defendants' statements regarding Aetna's business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this information was released to the public, the value of Aetna stock fell, causing investors harm. Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders' rights. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]

Read more...
AET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aetna Inc. and a Lead Plaintiff Deadline of March 27, 2017

NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Connecticut on behalf of investors who purchased Aetna Inc. (:AET) securities between August 15, 2016 through January 20, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/aetna-inc. There is no cost or obligation to you. According to the complaint, throughout the class period Aetna made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/aetna-inc. Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights.  Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

Read more...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 27, 2017 – AET

NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Aetna Inc. (:AET) between August 15, 2016 through January 20, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Connecticut. To get more information go to: http://www.zlk.com/pslra/aetna-inc or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you. The complaint alleges that throughout the class period Aetna made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. If you suffered a loss in Aetna you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com


Read more...
AET NOTICE: Rosen Law Firm Reminds Aetna Inc. Investors of Important Deadline in Class Action – AET

NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aetna Inc. securities (:AET) from August 15, 2016 through January 20, 2017, inclusive (the “Class Period”) of the important March 27, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Aetna investors under the federal securities laws. To join the Aetna class action, go to http://rosenlegal.com/cases-1039.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Aetna and its senior executives attempted to leverage Aetna’s participation in the Public Exchanges for favorable treatment from regulators regarding the Humana acquisition; (2) Aetna threatened to limit its participation in public health insurance exchanges if the Department of Justice (“DOJ”) attempted to block the merger; (3) Aetna did not withdraw from certain public health insurance exchanges for business reasons as Defendants claimed, but to follow through on its threat of leaving the marketplace once the DOJ filed suit and to improve its litigation position; (4) Aetna withdrew from public health insurance exchanges that were profitable for Aetna; and (5) as a result of the foregoing, Defendants’ statements about Aetna’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 27, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1039.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected]. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

Read more...
Momentum for FIDO Authentication Leads Evolution Beyond Passwords

200 FIDO Certified Products Are Now Available for Simpler, Stronger Authentication

MOUNTAIN VIEW, CA--(Marketwired - Jun 15, 2016) - Now is the time for the world to stop relying on passwords. This is clear as 63 percent of all data breaches involve the use of stolen, weak, or default passwords, while the recent LinkedIn, Myspace, Tumblr and Fling password leaks left 642 million accounts compromised and millions scrambling to change the old, simple passwords that they reuse across applications. Technology and service providers agree, and are backing a new standard to solve the password problem: FIDO strong authentication. The FIDO Alliance is the cross-industry consortia that provides a rich set of specifications and certifications for an emerging and interoperable ecosystem of hardware, mobile and biometrics-based devices. This ecosystem enables web service providers to deploy strong authentication solutions that reduce password dependencies and provide a superior, simpler and trusted user experience. The Alliance today announced a number of proof points highlighting the global adoption of FIDO authentication over the past 18 months since the FIDO specifications were released, and a mere 12 months since the launch of the FIDO® Certified program: The number of FIDO Certified products continues to expand.

More than 200 products from global technology leaders are now FIDO Certified, the Alliance announced today, giving service providers a diverse and flexible range of turnkey options to deploy FIDO standards. This represents a 100-percent increase since the start of 2016. Organizations with new FIDO Certified products announced today include: Austria Card; Aware, Inc.; Beijing SHENQI Technology Co. Ltd.; Century Longmai Technology Co., Ltd; Coolpad Group Limited; Goodix; GOTrust Technology Inc.; IDEX; Infineon Technologies; INITECH Co., Ltd.; Institute for Information Industry; KDDI CORPORATION; KONA I Co., Ltd; Koscom Corporation; KT; KYOCERA Corporation; Ledger; LeEco; Lenovo; LG Uplus; Lightfactor; Neoframe, Inc.; Open Security Research (OSR); Penta Security Systems Inc.; Safran Identity & Security; SGA Solutions Co., Ltd.; Shenzhen Excelsecu Data Technology Co., Ltd; VASCO Data Security International; Yubico. These latest certifications include the first FIDO Certified products that support Bluetooth® for wireless strong authentication. With these products, the Bluetooth authenticator needs only to be near a Bluetooth-enabled device for the user to be strongly authenticated to web apps on that device. More details on the latest FIDO Certified products and updates to the program are the focus of a June 23rd FIDO Alliance webinar at 2 pm EDT. To register, visit https://fidoalliance.org/events/fido_certification_validating_next_generation_auth/. FIDO authentication is increasingly available for online authentication.

FIDO authentication is now enabled on devices from the top five global handset manufacturers. Additionally, service providers including Google, PayPal, Samsung, Bank of America, NTT DOCOMO, Dropbox, GitHub and GOV.UK Verify have made FIDO authentication available to protect hundreds of millions of end-users' desktop and mobile apps, while RSA and eBay are among the many companies that have launched FIDO Certified solutions to facilitate enterprise and commercial deployments. Coming soon: Microsoft also will be integrating FIDO into Windows 10 for passwordless authentication, while the FIDO Alliance is working with the World Wide Web Consortium (W3C) to standardize FIDO strong authentication across all web browsers and related web platform infrastructure. Service providers are realizing the benefits from deploying FIDO.

In a recently-published two-year study of its FIDO deployment with security keys, Google revealed that using FIDO strong authentication is markedly faster than other strong authentication methods, has zero authentication failures, reduces hardware and support costs over one-time password (OTP) tokens, and provides all of the necessary privacy and security protections from phishing and man-in-the-middle attacks. According to Google, "our users have been very happy with the switch: we received many instances of unsolicited positive feedback." FIDO strong authentication is simpler than other options.

FIDO authentication is much simpler than remembering all kinds of passwords or other forms of strong authentication. The user simply needs to look at something (iris scan, facial recognition), touch something (fingerprint sensor, security key, wearable), say something (voice recognition) to be securely authenticated to any online service that supports FIDO. For security, FIDO uses public key cryptography and is strongly resistant to phishing, while user credentials and biometric templates are never stored on servers and never leave the user's device. "When we started tackling the password problem, we knew that our solution first and foremost would have to be based on proven security to stop the ongoing onslaught of data breaches," said Brett McDowell, executive director of the FIDO Alliance. "Second, users will have to actually want to use it. And third, it would have to be an open industry standard so it could become ubiquitously adopted by the whole internet ecosystem. This is what we have designed with FIDO, and as the adoption momentum demonstrates, we are well on the path towards that ubiquity." Learn more about the FIDO Alliance, FIDO standards and certification at www.fidoalliance.org. About FIDO® Certified

FIDO certification testing is based on industry-standard best practices to objectively evaluate technical implementations of the FIDO specifications. FIDO certification is open to all who want to offer FIDO authentication in products and services compliant with FIDO specifications. There are two options for FIDO certification testing: interoperability testing events or on-demand testing. The next FIDO Certified interoperability testing events will take place on August 30, 2016 for FIDO U2F and August 31 and September 1, 2016 for FIDO UAF. Subsequent testing sessions will occur approximately every 90 days or as demand dictates. Detailed information about the program and testing registration may be found at the FIDO Alliance website. On Demand Testing has been introduced as an alternative to attending interoperability events. On Demand Testing is available year-round, with three options: virtual; shipped; and in-person. For more details, visit the FIDO Alliance website. About the FIDO Alliance

The FIDO Alliance, www.fidoalliance.org, was formed in July 2012 to address the lack of interoperability among strong authentication technologies, and remedy the problems users face with creating and remembering multiple usernames and passwords. The FIDO Alliance is changing the nature of authentication with standards for simpler, stronger authentication that define an open, scalable, interoperable set of mechanisms that reduce reliance on passwords. FIDO authentication is stronger, private, and easier to use when authenticating to online services. The FIDO Alliance Board of Directors includes leading global organizations: Aetna, Inc. (NYSE: AET); Alibaba Holdings (NYSE: BABA); American Express (NYSE: AXP); ARM Holdings plc (LSE: ARM) (NASDAQ: ARMH); Bank of America Corporation (NYSE: BAC); BC Card; CrucialTec (KRX: 114120); Daon; Egis; Google (NASDAQ: GOOG); Intel (NASDAQ: INTC); ING (NYSE: ING); Infineon Technologies AG (FSE: IFX) (OTCQX: IFNNY); Lenovo (NASDAQ: LNVGY); MasterCard (NYSE: MA); Microsoft (NASDAQ: MSFT); Nok Nok Labs, Inc.; NTT DOCOMO, INC. (NYSE: DCM); NXP Semiconductors N.V. (NASDAQ: NXPI); Oberthur Technologies OT; PayPal (NASDAQ: PYPL); Qualcomm, Inc. (NASDAQ: QCOM); RSA®; Samsung Electronics, Ltd (KOSCOM: SECL); Synaptics (NASDAQ: SYNA); USAA; VASCO Data Security International, Inc. (NASDAQ: VDSI); Visa Inc. (NYSE: V); Yubico.

Contact

Megan Shamas

Montner Tech PR

203-226-9290

Email Contact





Read more...

Ratios

vs
industry
vs
history
PE Ratio 45.57
AET's PE Ratio is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.35 vs. AET: 45.57 )
Ranked among companies with meaningful PE Ratio only.
AET' s PE Ratio Range Over the Past 10 Years
Min: 5.42  Med: 12.63 Max: 45.58
Current: 45.57
5.42
45.58
Forward PE Ratio 16.37
AET's Forward PE Ratio is ranked higher than
53% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.62 vs. AET: 16.37 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 45.57
AET's PE Ratio without NRI is ranked higher than
60% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.38 vs. AET: 45.57 )
Ranked among companies with meaningful PE Ratio without NRI only.
AET' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.58
Current: 45.57
5.42
45.58
Price-to-Owner-Earnings 25.93
AET's Price-to-Owner-Earnings is ranked lower than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.58 vs. AET: 25.93 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AET' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 12.54 Max: 25.94
Current: 25.93
5.35
25.94
PB Ratio 3.40
AET's PB Ratio is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.55 vs. AET: 3.40 )
Ranked among companies with meaningful PB Ratio only.
AET' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.83 Max: 3.4
Current: 3.4
0.88
3.4
PS Ratio 0.82
AET's PS Ratio is ranked lower than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.57 vs. AET: 0.82 )
Ranked among companies with meaningful PS Ratio only.
AET' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.54 Max: 1.13
Current: 0.82
0.29
1.13
Price-to-Free-Cash-Flow 20.19
AET's Price-to-Free-Cash-Flow is ranked lower than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.11 vs. AET: 20.19 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AET' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.49  Med: 11.46 Max: 23.57
Current: 20.19
4.49
23.57
Price-to-Operating-Cash-Flow 18.13
AET's Price-to-Operating-Cash-Flow is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.41 vs. AET: 18.13 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AET' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.68  Med: 9.69 Max: 18.13
Current: 18.13
3.68
18.13
EV-to-EBIT 18.57
AET's EV-to-EBIT is ranked higher than
86% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.77 vs. AET: 18.57 )
Ranked among companies with meaningful EV-to-EBIT only.
AET' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.7  Med: 6.85 Max: 18.8
Current: 18.57
2.7
18.8
EV-to-EBITDA 14.92
AET's EV-to-EBITDA is ranked higher than
64% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.48 vs. AET: 14.92 )
Ranked among companies with meaningful EV-to-EBITDA only.
AET' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.4  Med: 5.9 Max: 15.1
Current: 14.92
2.4
15.1
PEG Ratio 4.19
AET's PEG Ratio is ranked higher than
50% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.87 vs. AET: 4.19 )
Ranked among companies with meaningful PEG Ratio only.
AET' s PEG Ratio Range Over the Past 10 Years
Min: 0.25  Med: 0.94 Max: 6.51
Current: 4.19
0.25
6.51
Shiller PE Ratio 30.02
AET's Shiller PE Ratio is ranked higher than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.26 vs. AET: 30.02 )
Ranked among companies with meaningful Shiller PE Ratio only.
AET' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.36  Med: 19.13 Max: 44.8
Current: 30.02
10.36
44.8
Current Ratio 0.77
AET's Current Ratio is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.21 vs. AET: 0.77 )
Ranked among companies with meaningful Current Ratio only.
AET' s Current Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.88 Max: 2.78
Current: 0.77
0.54
2.78
Quick Ratio 0.77
AET's Quick Ratio is ranked higher than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.15 vs. AET: 0.77 )
Ranked among companies with meaningful Quick Ratio only.
AET' s Quick Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.88 Max: 2.78
Current: 0.77
0.54
2.78
Days Sales Outstanding 31.57
AET's Days Sales Outstanding is ranked lower than
63% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.01 vs. AET: 31.57 )
Ranked among companies with meaningful Days Sales Outstanding only.
AET' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.34  Med: 26.33 Max: 31.57
Current: 31.57
16.34
31.57
Days Payable 50.55
AET's Days Payable is ranked higher than
67% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 42.29 vs. AET: 50.55 )
Ranked among companies with meaningful Days Payable only.
AET' s Days Payable Range Over the Past 10 Years
Min: 38.83  Med: 47.09 Max: 52.51
Current: 50.55
38.83
52.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.86
AET's Dividend Yield % is ranked lower than
81% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.29 vs. AET: 0.86 )
Ranked among companies with meaningful Dividend Yield % only.
AET' s Dividend Yield % Range Over the Past 10 Years
Min: 0.05  Med: 0.77 Max: 1.77
Current: 0.86
0.05
1.77
Dividend Payout Ratio 0.31
AET's Dividend Payout Ratio is ranked higher than
85% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. AET: 0.31 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AET' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.12 Max: 0.31
Current: 0.31
0.01
0.31
3-Year Dividend Growth Rate 7.70
AET's 3-Year Dividend Growth Rate is ranked higher than
50% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. AET: 7.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AET' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 171.4
Current: 7.7
0
171.4
Forward Dividend Yield % 1.39
AET's Forward Dividend Yield % is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.52 vs. AET: 1.39 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.85
AET's 5-Year Yield-on-Cost % is ranked lower than
76% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.08 vs. AET: 1.85 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AET' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.11  Med: 1.62 Max: 3.72
Current: 1.85
0.11
3.72
3-Year Average Share Buyback Ratio 1.00
AET's 3-Year Average Share Buyback Ratio is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. AET: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AET' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: 0.6 Max: 8.8
Current: 1
-10.2
8.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 21.64
AET's Price-to-Tangible-Book is ranked lower than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.31 vs. AET: 21.64 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AET' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.55  Med: 3.62 Max: 23.42
Current: 21.64
0.55
23.42
Price-to-Intrinsic-Value-Projected-FCF 1.09
AET's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. AET: 1.09 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AET' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.23  Med: 0.68 Max: 2
Current: 1.09
0.23
2
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.17
AET's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.39 vs. AET: 3.17 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.52
AET's Price-to-Median-PS-Value is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.91 vs. AET: 1.52 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AET' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.84 Max: 2.35
Current: 1.52
0.29
2.35
Price-to-Peter-Lynch-Fair-Value 4.81
AET's Price-to-Peter-Lynch-Fair-Value is ranked lower than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.50 vs. AET: 4.81 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AET' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.19  Med: 0.83 Max: 5.14
Current: 4.81
0.19
5.14
Price-to-Graham-Number 6.62
AET's Price-to-Graham-Number is ranked higher than
50% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.61 vs. AET: 6.62 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AET' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.36  Med: 1.52 Max: 6.62
Current: 6.62
0.36
6.62
Earnings Yield (Greenblatt) % 5.38
AET's Earnings Yield (Greenblatt) % is ranked higher than
86% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.29 vs. AET: 5.38 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AET' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.3  Med: 14.65 Max: 37.5
Current: 5.38
5.3
37.5
Forward Rate of Return (Yacktman) % 14.71
AET's Forward Rate of Return (Yacktman) % is ranked higher than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.81 vs. AET: 14.71 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AET' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 2.3  Med: 19.8 Max: 54.9
Current: 14.71
2.3
54.9

More Statistics

Revenue (TTM) (Mil) $62,627
EPS (TTM) $ 3.21
Beta0.62
Short Percentage of Float3.01%
52-Week Range $104.59 - 144.87
Shares Outstanding (Mil)331.72

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 60,569 62,515 66,028
EPS ($) 8.75 9.90 11.08
EPS without NRI ($) 8.75 9.90 11.08
EPS Growth Rate
(Future 3Y To 5Y Estimate)
14.64%
Dividends per Share ($) 1.34 1.34 1.50
» More Articles for NYSE:AET

Headlines

Articles On GuruFocus.com
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna May 23 2017 
Insiders Roundup: Facebook, General Electric, Aetna May 19 2017 
Eaton Vance Worldwide Health Sciences Fund Adds 4 Companies May 17 2017 
Diamond Hill Sells Morgan Stanley and IBM, Buys Pepsi Mar 28 2017 
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aetna I Mar 24 2017 
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aetna Inc. and Encou Mar 24 2017 
Pioneer Investments Exits Wells Fargo, Coca-Cola, Buys Walt Disney Mar 24 2017 
AET INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Act Mar 21 2017 
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Aetna Inc. of a Class Action Lawsuit and Mar 17 2017 
AET NOTICE: Rosen Law Firm Reminds Aetna Inc. Investors of Important Deadline in Class Action – Mar 02 2017 

More From Other Websites
Insurer Exit Leaves 25 Missouri Counties With No ACA Plans for 2018 May 24 2017
Aetna Board of Directors Declares Quarterly Cash Dividend May 19 2017
Analysts’ Recommendations for WellCare Health Plans in May 2017 May 17 2017
Carly Fiorina: 'Pre-Existing Conditions Have to Be Covered' in Health Care Reform May 15 2017
150-Year-Old Aetna Pitches Itself As A Growth Company May 15 2017
Post Earnings Coverage as Aetna's Adjusted EPS Jumped 17% May 15 2017
Anthem gives up Cigna bid, vows to fight on over damages May 12 2017
Aetna CEO urges debate on what 'single-payer' healthcare would be May 12 2017
Why prescription drug prices keep going up May 12 2017
Blog Coverage: Obamacare Receives Another Jolt as Health Insurer Aetna Announces Withdrawal from all... May 12 2017
More price hikes likely for government insurance markets May 11 2017
Delaware Judge Allows Cigna to Escape Anthem Deal May 11 2017
Aetna pulls out of Obamacare May 11 2017
What it means for most Americans when insurers bail on Obamacare May 11 2017
Why Aetna pulling out doesn't mean Obamacare is imploding May 11 2017
Aetna drops last 2 state markets under Affordable Care Act May 11 2017
Aetna to be totally out of Obamacare marketplace program in 2018 May 11 2017
How to Trade 5 Insurers Despite Pending Healthcare Reforms May 11 2017
Whole Foods shakes up management, and other MoneyWatch headlines May 11 2017
Aetna (AET) Calls it Quits on Unsustainable Public Exchanges May 11 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)